Significant reduction in end‐stage liver diseases burden through the national viral hepatitis therapy program in Taiwan
Chun‐Ju Chiang(National Taiwan University), Chien‐Jen Chen(Genomics Research Center, Academia Sinica), Mei‐Shu Lai(National Taiwan University), Mei‐Hsuan Lee(National Yang Ming Chiao Tung University), Jin‐De Chen(National Taiwan University Hospital), San‐Lin You(National Taiwan University), Ya‐Wen Yang(National Taiwan University), Hwai‐I Yang(Chang Gung University)
Cited by 109
Related Papers
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
|Gastroenterology|2006|1.5k
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
|JNCI Journal of the National Cancer Institute|2005|569
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|Gastroenterology|2008|547
Epidemiological characteristics and risk factors of hepatocellular carcinoma
|Journal of Gastroenterology and Hepatology|1997|473